Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated (VRTX)

$445.21

Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast
Currently 37 wall-street analysts regularly analyze the financials of Vertex Pharmaceuticals Incorporated on a frequent basis to provide recommendations along with target share price. 37 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Incorporated (VRTX) have a share price target of $467.42. This median of share price forecast represents a 4.99% upside from the latest price of $445.21 as on 19.05.24.

Vertex Pharmaceuticals Incorporated (VRTX) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Vertex Pharmaceuticals Incorporated (VRTX) share price will touch around $467.42 in next 12-months.
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Vertex Pharmaceuticals Incorporated's share price and its median forecast price. As on 19.05.24, the difference is -13.97%

Vertex Pharmaceuticals Incorporated (VRTX): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Vertex Pharmaceuticals Incorporated (VRTX) Share Price : Analyst Recommendation
Based on 37 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
16
16
17
Outperform
10
10
10
Hold
11
10
10
Underperform
0
0
0
Sell
0
0
0
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Vertex Pharmaceuticals Incorporated (VRTX) is $467.42, offered by 37 analysts offering 12-month price forecasts.

Vertex Pharmaceuticals Incorporated (VRTX) has a maximum of 0.05 upside potential, based on 37 analysts offering 12-month price forecasts.

Based on 37 analysts tracking and researching Vertex Pharmaceuticals Incorporated (VRTX), 72.97% have a buy recommendation. Remaining 27.03% have either sell or hold recommendations.

The latest share price of Vertex Pharmaceuticals Incorporated (VRTX) is $445.21 as of 19/05/2024.

27 of total 37 analysts offering stock ratings for Vertex Pharmaceuticals Incorporated VRTX have recommended buy rating.